The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versanis Bio's bimagrumab, which prevents the activity of a ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.

Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on “every country” that hits U.S. products coming into their countries with ...

Consequently, food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...

The Fund lagged the benchmark composite index, which was up 15.01%, while the Fund underperformed the Morningstar Moderate ...

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.